Andrew Peter Marsden
Gründer bei Immaterial Ltd.
Profil
Andrew Peter Marsden is the founder and current Director of Vector Bioscience Ltd.
He founded Immaterial Ltd.
in 2015 and serves as its Chief Executive Officer & Director.
Aktive Positionen von Andrew Peter Marsden
| Unternehmen | Position | Beginn |
|---|---|---|
Immaterial Ltd.
 Immaterial Ltd. Industrial MachineryProducer Manufacturing Immaterial Labs Ltd. manufactures super-adsorbent nanomaterial's for the storage and separation of gas molecules. The firm manufactures monolithic MOFs which enable gases to be adsorbed at the molecular level without the need for high compression or liquefaction. The company was founded by Andrew Marsden, David Fairen-Jimenez and Tian Tian on October 19, 2015 and is headquartered in Cambridge, the United Kingdom. | Gründer | 19.10.2015 |
Vector Bioscience Ltd.
 Vector Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Vector Bioscience Ltd. engages in the manufacture of pharmaceutical products. The company was founded on March 11, 2020 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 11.03.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Immaterial Ltd.
Immaterial Ltd. Industrial MachineryProducer Manufacturing Immaterial Labs Ltd. manufactures super-adsorbent nanomaterial's for the storage and separation of gas molecules. The firm manufactures monolithic MOFs which enable gases to be adsorbed at the molecular level without the need for high compression or liquefaction. The company was founded by Andrew Marsden, David Fairen-Jimenez and Tian Tian on October 19, 2015 and is headquartered in Cambridge, the United Kingdom. | Producer Manufacturing |
Vector Bioscience Ltd.
Vector Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Vector Bioscience Ltd. engages in the manufacture of pharmaceutical products. The company was founded on March 11, 2020 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
